Ingela Björholt

866 total citations
32 papers, 656 citations indexed

About

Ingela Björholt is a scholar working on Economics and Econometrics, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ingela Björholt has authored 32 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Economics and Econometrics, 9 papers in Oncology and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ingela Björholt's work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Colorectal Cancer Surgical Treatments (5 papers). Ingela Björholt is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (9 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Colorectal Cancer Surgical Treatments (5 papers). Ingela Björholt collaborates with scholars based in Sweden, France and Netherlands. Ingela Björholt's co-authors include Eva Haglind, B Anderberg, Martin Janson, E. Lindholm, Martin Henriksson, Per Carlsson, Eva Lesén, Lennart Bergfeldt, Eva Haglind and Eva Angenete and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Urology.

In The Last Decade

Ingela Björholt

32 papers receiving 625 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ingela Björholt Sweden 14 253 227 200 167 89 32 656
Donald J. Lucas United States 17 504 2.0× 224 1.0× 275 1.4× 170 1.0× 78 0.9× 34 949
Jacob D. Gundrum United States 13 238 0.9× 109 0.5× 80 0.4× 97 0.6× 19 0.2× 26 747
Philip Lewis United Kingdom 15 138 0.5× 242 1.1× 426 2.1× 39 0.2× 53 0.6× 60 938
Lingsong Yun Canada 18 236 0.9× 294 1.3× 498 2.5× 204 1.2× 81 0.9× 43 1.0k
Hirokazu Konishi Japan 19 418 1.7× 105 0.5× 533 2.7× 89 0.5× 23 0.3× 53 948
Lucas E. Nikkel United States 17 458 1.8× 208 0.9× 175 0.9× 143 0.9× 21 0.2× 27 1.0k
Sean Virani Canada 19 122 0.5× 145 0.6× 707 3.5× 315 1.9× 29 0.3× 71 1.0k
Julia B. Finkelstein United States 15 191 0.8× 118 0.5× 89 0.4× 205 1.2× 41 0.5× 49 744
Adan Z. Becerra United States 22 703 2.8× 745 3.3× 125 0.6× 231 1.4× 67 0.8× 49 1.3k
Eugene B. Cone United States 13 112 0.4× 173 0.8× 42 0.2× 253 1.5× 74 0.8× 49 652

Countries citing papers authored by Ingela Björholt

Since Specialization
Citations

This map shows the geographic impact of Ingela Björholt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingela Björholt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingela Björholt more than expected).

Fields of papers citing papers by Ingela Björholt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingela Björholt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingela Björholt. The network helps show where Ingela Björholt may publish in the future.

Co-authorship network of co-authors of Ingela Björholt

This figure shows the co-authorship network connecting the top 25 collaborators of Ingela Björholt. A scholar is included among the top collaborators of Ingela Björholt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingela Björholt. Ingela Björholt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Angenete, Eva, et al.. (2019). Cost-effectiveness analysis of laparoscopic and open surgery in routine Swedish care for colorectal cancer. Surgical Endoscopy. 34(10). 4403–4412. 21 indexed citations
3.
Forsmark, Annabelle, Eva Angenete, Anders Bjartell, et al.. (2018). Health Economic Analysis of Open and Robot-assisted Laparoscopic Surgery for Prostate Cancer Within the Prospective Multicentre LAPPRO Trial. European Urology. 74(6). 816–824. 53 indexed citations
4.
Lesén, Eva, Ingela Björholt, Anders Ingelgård, & Fredrik J. Olson. (2017). EXPLORATION AND PREFERENTIAL RANKING OF PATIENT BENEFITS OF MEDICAL DEVICES: A NEW AND GENERIC INSTRUMENT FOR HEALTH ECONOMIC ASSESSMENTS. International Journal of Technology Assessment in Health Care. 33(4). 463–471. 13 indexed citations
5.
Lesén, Eva, Daniel Granfeldt, Aude Houchard, et al.. (2017). Overall survival in patients diagnosed with metastatic GEP-NET in Sweden. Annals of Oncology. 28. iii4–iii4. 1 indexed citations
6.
Björholt, Ingela, et al.. (2016). Health economic analysis of costs of laparoscopic and open surgery for rectal cancer within a randomized trial (COLOR II). Surgical Endoscopy. 31(3). 1225–1234. 9 indexed citations
7.
Lesén, Eva, Daniel Granfeldt, Aude Houchard, et al.. (2016). Cost-of-Illness of Acromegaly in Sweden – A Register-Linkage Population-Based Study. Value in Health. 19(7). A669–A669. 2 indexed citations
8.
Granfeldt, Daniel, et al.. (2015). The Cost Effectiveness of Delayed-Release Dimethyl Fumarate Versus Interferon Beta-1b In A Swedish Setting. Value in Health. 18(7). A757–A757. 4 indexed citations
9.
Lesén, Eva, Ingela Björholt, Åse Björstad, Martin Fahlén, & Anders Odén. (2014). Impact of short periods with worsened or improved INR control on life expectancy and QALYs in patients with atrial fibrillation. Thrombosis Research. 133(6). 1061–1067. 4 indexed citations
10.
Lesén, Eva, Ingela Björholt, Åse Björstad, Martin Fahlén, & Anders Odén. (2013). Impact of Short Periods with Improved or Worsened INR Control on Life Expectancy and QALYs in Patients with Atrial Fibrillation. Value in Health. 16(7). A328–A328. 1 indexed citations
11.
Lesén, Eva, et al.. (2013). Dose Patterns among Patients Using Low-Dose Buprenorphine Patches. Pain Medicine. 14(9). 1374–1380. 2 indexed citations
12.
Ambring, Anneli, Ingela Björholt, Eva Lesén, Ulrika Stierner, & Anders Odén. (2012). Treatment with sorafenib and sunitinib in renal cell cancer: a Swedish register-based study. Medical Oncology. 30(1). 331–331. 13 indexed citations
13.
Ambring, Anneli, Ulrika Stierner, Anders Odén, & Ingela Björholt. (2011). Sorafenib and sunitinib in renal cell cancer: A study based on register data.. Journal of Clinical Oncology. 29(15_suppl). 4600–4600. 2 indexed citations
14.
Ryttberg, Lars, et al.. (2011). Cost–effectiveness of rivaroxaban versus heparins for prevention of venous thromboembolism after total hip or knee surgery in Sweden. Expert Review of Pharmacoeconomics & Outcomes Research. 11(5). 601–615. 24 indexed citations
15.
Bergfeldt, Lennart, et al.. (2010). Atrial fibrillation: the cost of illness in Sweden. The European Journal of Health Economics. 12(5). 479–487. 48 indexed citations
16.
Björholt, Ingela, et al.. (2007). The cost of monitoring warfarin in patients with chronic atrial fibrillation in primary care in Sweden. BMC Family Practice. 8(1). 6–6. 25 indexed citations
17.
Björholt, Ingela, et al.. (2006). Resource consumption and management associated with monitoring of warfarin treatment in primary health care in Sweden. BMC Family Practice. 7(1). 67–67. 8 indexed citations
18.
19.
20.
Björholt, Ingela, Fredrik Andersson, Thomas Kahan, & Jan Östergren. (2002). The cost‐effectiveness of ramipril in the treatment of patients at high risk of cardiovascular events: a Swedish sub‐study to the HOPE study. Journal of Internal Medicine. 251(6). 508–517. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donald J. Lucas Breakdown of academic impact, for papers by Jacob D. Gundrum Breakdown of academic impact, for papers by Philip Lewis Breakdown of academic impact, for papers by Lingsong Yun Breakdown of academic impact, for papers by Hirokazu Konishi Breakdown of academic impact, for papers by Lucas E. Nikkel Breakdown of academic impact, for papers by Sean Virani Breakdown of academic impact, for papers by Julia B. Finkelstein Breakdown of academic impact, for papers by Adan Z. Becerra Breakdown of academic impact, for papers by Eugene B. Cone
Rankless by CCL
2026